Launch of the Next Generation T-Track® CMV Immune Monitoring Tool
Lophius Biosciences GmbH today announced the launch of the next generation of its in vitro diagnostic test T-Track® CMV for the risk stratification of human cytomegalovirus (CMV)-related clinical complications in transplant recipients. The new version of the CE-marked immune monitoring Mehr